Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
04/2010
04/07/2010CN101214366B Chinese medicine preparation for treating gout and rheumatism
04/07/2010CN100998660B Traditional Chinese medicine plaster for treating vertebral artery type cervical spondylosis and its preparing method
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
04/06/2010US7691891 Diphenylurea derivatives and their use as chloride channel blockers
04/06/2010US7691845 Anti-inflammatory agents
04/06/2010US7691591 Methods of identifying and isolating cells expressing DC-sign
04/06/2010US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
04/06/2010CA2513738C Casr antagonist
04/06/2010CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them
04/01/2010WO2010036567A2 Harmine compounds for promoting bone growth
04/01/2010WO2010036146A1 Use of fc fragments of class g immunoglobulin as an antigen for treating rheumatoid arthritis, agent and method of treatment
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035769A1 Improved antibody molecule
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035013A1 Krill oil powder and krill oil tablets
04/01/2010WO2010034806A1 Anhydrate and hydrate forms of strontium ranelate
04/01/2010WO2010034790A1 Protease inhibitors
04/01/2010WO2010034789A1 Protease inhibitors
04/01/2010WO2010034788A1 Protease inhibitors
04/01/2010WO2010010157A3 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
04/01/2010WO2009143064A3 Rice bran extracts for inflammation and methods of use thereof
04/01/2010WO2009086952A3 Compositions for the treatment of degenerative articular diseases
04/01/2010WO2009016451A9 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081677 Heteroarylamide pyrimidone derivatives
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010US20100081640 Pharmaceutical composition
04/01/2010US20100081612 Polypeptide derivatives of parathyroid hormone (pth)
04/01/2010US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof
04/01/2010US20100080848 Recombinant Lubricin Molecules and Uses Thereof
04/01/2010US20100080836 Method and means for culturing osteoblastic cells
04/01/2010US20100080812 Antibodies against human IL17 and uses thereof
04/01/2010CA2738878A1 Selective estrogen receptor modulator for the treatment of osteoarthritis
04/01/2010CA2738147A1 Solid pharmaceutical composition
04/01/2010CA2738025A1 Protease inhibitors
04/01/2010CA2738023A1 Protease inhibitors
03/2010
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof
03/31/2010EP2168602A1 Site-specific pegylated linear salmon calcitonin derivatives
03/31/2010EP2168440A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
03/31/2010EP2167543A1 Antigen binding proteins that bind par-2
03/31/2010EP2167507A1 Cysteine protease inhibitors
03/31/2010EP2167136A2 Molecules for targeting compounds to various selected organs or tissues
03/31/2010CN101688177A Hepatocytes and chondrocytes from adherent placental stem cells and cd34+, cd45- placental stem cell-enriched cell populations
03/31/2010CN101687880A Cysteine protease inhibitors
03/31/2010CN101687864A 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors
03/31/2010CN101687838A Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/31/2010CN101687016A Activin-actriia antagonists and uses for promoting bone growth in cancer patients
03/31/2010CN101687014A compositions and methods for treating pathologic angiogenesis and vascular permeability
03/31/2010CN101686953A Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
03/31/2010CN101686936A Use of a natural polysaccharide gel for production of an injectable formulation for treating joint degeneration
03/31/2010CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
03/31/2010CN101684156A Human TNF alpha monoclonal antibody, PEGylation nanoparticle and application thereof
03/31/2010CN101684108A 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-5-thiazole formic acid and composition thereof
03/31/2010CN101684107A New febuxostat crystal form and preparing method thereof
03/31/2010CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/31/2010CN101683516A Pharmaceutical composition for treating injuries from falls and rheumatism and preparation method thereof
03/31/2010CN101683400A Preparation method of pill for treating three kinds of spinal arthralgia
03/31/2010CN101683381A Preparation method of pill containing longfang and notopterygium
03/31/2010CN101683378A Pharmaceutical composition for treating bi syndrome
03/31/2010CN101683374A Patch for treating disc herniation and method for producing the same
03/31/2010CN101683373A Preparation method of medicine ironing bag for treating rheumatism
03/31/2010CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN100596278C Medicinal composition for preventing and treating senile osteoarthropathy
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
03/30/2010US7687485 Formulation for menopausal women
03/30/2010US7687480 Phosphonate compounds
03/30/2010US7687460 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010CA2496121C Stable formulations of hyaluronic acid for use in the therapeutic treatment of arthropathy
03/30/2010CA2436667C Novel bioactive substance
03/30/2010CA2349980C Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
03/25/2010WO2010034011A2 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
03/25/2010WO2010034003A2 Benzylthiotetrazole inhibitors of store operated calcium release
03/25/2010WO2010033981A2 5-azaindole bisphosphonates
03/25/2010WO2010033980A2 4-azaindole bisphosphonates
03/25/2010WO2010032448A1 Sheet for repairing cartilage defect site
03/25/2010WO2010032010A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use
03/25/2010WO2010031876A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/25/2010WO2010031852A1 Novel estrogen receptor ligands
03/25/2010WO2010031248A1 Thiazolium salt compound and the use of treating the protein aging disease
03/25/2010WO2010008976A3 Combined calcium, magnesium and vitamin d supplements
03/25/2010WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
03/25/2010WO2010004283A3 Sulfonylurea receptor and means for treating ischaemia
03/25/2010WO2009155056A3 Non-hormonal steroid modulators of nf-kb for treatment of disease
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 820